These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31152746)

  • 21. Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.
    Chvatal A; Ambrus R; Party P; Katona G; Jójárt-Laczkovich O; Szabó-Révész P; Fattal E; Tsapis N
    Int J Pharm; 2019 Mar; 559():68-75. PubMed ID: 30677482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
    Weers JG; Miller DP; Tarara TE
    AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis.
    Fan C; Eedara BB; Sinha S; Uddin MKM; Doyle C; Banu S; Das SC
    Int J Pharm; 2024 Apr; 654():123984. PubMed ID: 38461874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical aerosols for the treatment and prevention of tuberculosis.
    Hanif SN; Garcia-Contreras L
    Front Cell Infect Microbiol; 2012; 2():118. PubMed ID: 22973562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
    Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
    Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599.
    Stewart IE; Lukka PB; Liu J; Meibohm B; Gonzalez-Juarrero M; Braunstein MS; Lee RE; Hickey AJ
    Pharm Res; 2019 Jul; 36(9):136. PubMed ID: 31321552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.
    Shao Z; Tam KK; Achalla VPK; Woon ECY; Mason AJ; Chow SF; Yam WC; Lam JKW
    Int J Pharm; 2024 Apr; 654():123960. PubMed ID: 38447778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and Characterization of Spray-Dried Powders Containing Vincristine-Liposomes for Pulmonary Delivery and Its Pharmacokinetic Evaluation From In Vitro and In Vivo.
    Xu J; Lu X; Zhu X; Yang Y; Liu Q; Zhao D; Lu Y; Wen J; Chen X; Li N
    J Pharm Sci; 2019 Oct; 108(10):3348-3358. PubMed ID: 31103789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capreomycin supergenerics for pulmonary tuberculosis treatment: preparation, in vitro, and in vivo characterization.
    Schoubben A; Blasi P; Marenzoni ML; Barberini L; Giovagnoli S; Cirotto C; Ricci M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):388-95. PubMed ID: 23220041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy.
    Shao Z; Tai W; Qiu Y; Man RCH; Liao Q; Chow MYT; Kwok PCL; Lam JKW
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation.
    Cuvelier B; Eloy P; Loira-Pastoriza C; Ucakar B; Sanogo AA; Dupont-Gillain C; Vanbever R
    Int J Pharm; 2015 Nov; 495(2):981-90. PubMed ID: 26456267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhalable formulations of rifampicin by spray drying of supersaturated aqueous solutions.
    Berkenfeld K; McConville JT; Lamprecht A
    Eur J Pharm Biopharm; 2020 Aug; 153():14-22. PubMed ID: 32446961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK
    J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.